Akero Therapeutics
AcquiredAkero Therapeutics is a life sciences company in South San Francisco, United States, founded in 2017. It has raised $135.0M across 2 rounds, most recently a $70.0M Series B in December 2018.
EFX for MASH | Metabolic Disease | Home
- Headquarters
- South San Francisco
- Employees
- 11–50
- Founded
- 2017
- Website
- akerotx.com
- Total Funding
- $135.0M
- Last Round
- $70.0M Series BDec 2018
- Rounds
- 2
- Acquisition Date
- Jan 2025
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.
About
Akero Therapeutics is a clinical-stage biopharmaceutical company founded in 2017 to develop transformational treatments for patients with metabolic dysfunction-associated steatohepatitis (MASH) and other serious metabolic diseases. Its lead candidate, efruxifermin (EFX), advanced through Phase 3 trials before Novo Nordisk acquired Akero in 2025 to expand access to the therapy. The company is headquartered in South San Francisco, California.
Summary
It lists 11–50 employees. It has raised $135.0M in total across 2 rounds, most recently a $70.0M Series B round in Dec 2018. Investors include Novo Nordisk and Apple.
Tech & App Stack
5 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding & Exit History
Oct 2025
Sign up to see all 5 events
Funding: Series A through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/akero"><img src="https://indexed.vc/api/badge/company/akero" alt="Akero Therapeutics on Indexed.vc" width="260" height="76" /></a>


